Trump Tries to Sell Americans Iran War
Digest
President Trump addressed the nation, asserting the benefits of the ongoing war in Iran and predicting a swift economic recovery, despite cautious investor sentiment. Eli Lilly secured approval for a daily GLP-1 pill, poised to compete with Novo Nordisk's successful Uygovi, with analysts projecting significant sales. Additionally, the Trump administration is considering changes to steel and aluminum tariffs, which could impose a 25% tariff on the total value of goods made with imported metals.
Outlines

Geopolitical and Economic Updates
President Trump discussed the month-old war in Iran, highlighting its benefits to America and forecasting a rapid economic recovery. However, markets showed caution, with stock futures and Asian markets declining.

Pharmaceutical Advancements and Market Competition
Eli Lilly received regulatory approval for its daily GLP-1 pill, positioning it as a competitor to Novo Nordisk's successful Uygovi. Analysts anticipate substantial global sales for Lilly's new oral medication, building on the success of their existing GLP-1 injections.

Trade Policy: Steel and Aluminum Tariffs
The Trump administration is contemplating changes to steel and aluminum tariffs. A potential shift could implement a 25% tariff on the entire value of goods manufactured using imported steel and aluminum, a departure from the current duty structure.
Keywords
GLP-1 pill
Eli Lilly's new daily oral medication for competing with Novo Nordisk's Uygovi in the weight management and diabetes market.
Steel and Aluminum Tariffs
Potential changes to U.S. trade policies on imported metals, possibly affecting the value of manufactured goods.
Uygovi
Novo Nordisk's successful GLP-1 medication, a key competitor in the pharmaceutical market.
Iran War
A month-long conflict discussed by President Trump, framed as beneficial to American interests.
Economic Recovery
President Trump's prediction of a swift rebound in the U.S. economy.
Q&A
What was President Trump's message regarding the war in Iran and the economy?
President Trump stated that the month-old war in Iran was in America's interests and predicted a rapid recovery in stock prices, emphasizing the U.S. economy's strength and daily improvement.
What is the significance of Eli Lilly's new GLP-1 pill approval?
Eli Lilly's approval for a once-daily GLP-1 pill signifies a major step in competing with Novo Nordisk's successful Uygovi. Analysts anticipate substantial global sales for Lilly's new oral medication.
How might the proposed changes to steel and aluminum tariffs affect imported goods?
The potential changes could impose a 25% tariff on the entire value of goods made with imported steel and aluminum, a shift from the current system that taxes only the value of the metals within a product.
Show Notes
Plus: Eli Lilly’s obesity pill gets approval, and will take on a rival from Novo Nordisk in the booming GLP-1 drug market. And the Trump Administration is expected to overhaul steel and aluminum tariffs. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices



